These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6419431)

  • 1. [Use of plasmapheresis in surgical hematology].
    Abdulkadyrov KM; Shatrov VA; Katsadze IuL
    Vestn Khir Im I I Grek; 1983 Oct; 131(10):125-8. PubMed ID: 6419431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
    Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR
    Haematologia (Budap); 1981; 14(1):49-56. PubMed ID: 6454615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
    Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
    Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasmapheresis and hyperviscosity syndrome].
    Corral Alonso M; Barbolla ML
    Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasmapheresis in the treatment of paraproteinemic hemoblastoses].
    Ryzhko VV; Gorodetskiĭ VM
    Ter Arkh; 1983; 55(11):70-5. PubMed ID: 6419367
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reestablishment of plasma proteins after plasmapheresis in patients with paraproteinemic hemoblastosis].
    Movshev BE; Kalinin NN; Petrov MM; Petrova VI
    Ter Arkh; 1999; 71(10):40-3. PubMed ID: 10612173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma viscosity changes after sham plasmapheresis.
    Jakoet A; Martell RW; Jacobs P
    Lancet; 1987 Oct; 2(8566):1031-2. PubMed ID: 2889944
    [No Abstract]   [Full Text] [Related]  

  • 8. [The monitoring of protein-volemic indices during plasmapheresis in patients with paraproteinemic hemoblastoses].
    Kalinin NN; Movshev BE; Petrov MM; Petrova VI; Droshneva VA; Varlamova SV; Khoroshko ND; Zhuravlev VS; Loginov SP
    Ter Arkh; 1996; 68(7):62-5. PubMed ID: 8928075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood volume and hematocrit value in macroglobulinemia and myeloma.
    Kopp WL; MacKinney AA; Wasson G
    Arch Intern Med; 1969 Apr; 123(4):394-6. PubMed ID: 4976452
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical utilization of plasmapheresis and cyclophosphamide in the treatment of malignant lymphoproliferative processes.
    Sakalová A; Gazová S; Hrubisko M; Gáliková J
    Neoplasma; 1973; 20(3):335-9. PubMed ID: 4199115
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
    Kaplan AA
    Ther Apher; 2001 Jun; 5(3):171-5. PubMed ID: 11467752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of emergency apheresis in the management of plasma cell disorders.
    Kalayoglu-Besisik S
    Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
    Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
    J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apheresis in hematologic and oncologic disease.
    Cohen RJ
    Hosp Pract (Off Ed); 1983 Oct; 18(10):199-205. PubMed ID: 6413369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nursing assessment of symptoms associated with hyperviscosity syndrome.
    Trotta P; Knobf MT
    Oncol Nurs Forum; 1987; 14(1):21-5. PubMed ID: 3101042
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical use of plasmapheresis].
    Del Favero A; Morelli A; Narducci F
    Clin Ter; 1981 Jan; 96(1):93-9. PubMed ID: 6786819
    [No Abstract]   [Full Text] [Related]  

  • 18. [Extracorporeal methods of therapy in lymphatic tumors].
    Ryzhko VV; Andreeva NE; Gorodetskiĭ VM; Konovalova VI; Aleksanian MZh; Sinitsina TV
    Ter Arkh; 1990; 62(7):59-63. PubMed ID: 2123573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperviscosity and disease].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Mar; 125(12):80, 82, 84. PubMed ID: 6406848
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasmapheresis].
    Speiser P
    Wien Klin Wochenschr; 1967 Sep; 79(38):689-92. PubMed ID: 4969820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.